Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

339 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A novel clinical prognostic score incorporating the number of resected lymph-nodes to predict recurrence and survival in non-small-cell lung cancer.
Bria E, Milella M, Sperduti I, Alessandrini G, Visca P, Corzani F, Giannarelli D, Cerasoli V, Cuppone F, Cecere FL, Marchetti A, Sacco R, Mucilli F, Malatesta S, Guetti L, Vitale L, Ceribelli A, Rinaldi M, Terzoli E, Cognetti F, Facciolo F. Bria E, et al. Among authors: visca p. Lung Cancer. 2009 Dec;66(3):365-71. doi: 10.1016/j.lungcan.2009.02.024. Epub 2009 Mar 27. Lung Cancer. 2009. PMID: 19327866
Determination of SGK1 mRNA in non-small cell lung cancer samples underlines high expression in squamous cell carcinomas.
Abbruzzese C, Mattarocci S, Pizzuti L, Mileo AM, Visca P, Antoniani B, Alessandrini G, Facciolo F, Amato R, D'Antona L, Rinaldi M, Felsani A, Perrotti N, Paggi MG. Abbruzzese C, et al. Among authors: visca p. J Exp Clin Cancer Res. 2012 Jan 12;31(1):4. doi: 10.1186/1756-9966-31-4. J Exp Clin Cancer Res. 2012. PMID: 22240294 Free PMC article.
Protumorigenic effects of mir-145 loss in malignant pleural mesothelioma.
Cioce M, Ganci F, Canu V, Sacconi A, Mori F, Canino C, Korita E, Casini B, Alessandrini G, Cambria A, Carosi MA, Blandino R, Panebianco V, Facciolo F, Visca P, Volinia S, Muti P, Strano S, Croce CM, Pass HI, Blandino G. Cioce M, et al. Among authors: visca p. Oncogene. 2014 Nov 13;33(46):5319-31. doi: 10.1038/onc.2013.476. Epub 2013 Nov 18. Oncogene. 2014. PMID: 24240684 Free PMC article.
Prognostic impact of alternative splicing-derived hMENA isoforms in resected, node-negative, non-small-cell lung cancer.
Bria E, Di Modugno F, Sperduti I, Iapicca P, Visca P, Alessandrini G, Antoniani B, Pilotto S, Ludovini V, Vannucci J, Bellezza G, Sidoni A, Tortora G, Radisky DC, Crinò L, Cognetti F, Facciolo F, Mottolese M, Milella M, Nisticò P. Bria E, et al. Among authors: visca p. Oncotarget. 2014 Nov 30;5(22):11054-63. doi: 10.18632/oncotarget.2609. Oncotarget. 2014. PMID: 25373410 Free PMC article.
An 18-year delay in the clinical presentation of bronchial carcinoid.
Leuzzi G, Forcella D, Melis E, Visca P, Facciolo F. Leuzzi G, et al. Among authors: visca p. Rev Esp Med Nucl Imagen Mol. 2015 Sep-Oct;34(5):327-8. doi: 10.1016/j.remn.2014.12.008. Epub 2015 Jan 24. Rev Esp Med Nucl Imagen Mol. 2015. PMID: 25630601 No abstract available.
Prognostic role of serum p53 antibodies in lung cancer.
Mattioni M, Soddu S, Prodosmo A, Visca P, Conti S, Alessandrini G, Facciolo F, Strigari L. Mattioni M, et al. Among authors: visca p. BMC Cancer. 2015 Mar 18;15:148. doi: 10.1186/s12885-015-1174-4. BMC Cancer. 2015. PMID: 25884692 Free PMC article.
339 results